돌아가기
Huagongshe화공사 화학 정보 인쇄 보고서 · 연구 참고용
HRID 1388495생성일: 2026년 10월 26일

Rifamycin S → Rifamycin

https://huagongshe.com/reaction/1388495

반응식

참여 물질

역할이름HCID투입량
반응물Rifamycin SHCID 6436726—
용매[(9E,19E,21Z)-2,15,17,29-tetrahydroxy-27-[2-(4-iodoanilino)-2-oxoethoxy]-11-methoxy-3,7,12,14,16,18,22-heptamethyl-6,23-dioxo-8,30-dioxa-24-azatetracyclo[23.3.1.14,7.05,28]triaconta-1(29),2,4,9,19,21,25,27-octaen-13-yl] acetateHCID 6507126—
생성물RifamycinHCID 6324616—

반응 조건

온도50 °C

반응 단계

Reaction--Ten grams of the enzyme adsorbed on celite were added to 300 ml of 1% rifamycin B solution (10 mM phosphate buffer, pH 8.5). The conversion to rifamycin S was completed in 7 hours of reaction at 40° C. with aeration and agitation. The celite filter cake recovered by filtration on a sintered glass was washed with 200 ml of methanol. The final methanolic aqueous solution of rifamycin S was warmed to 50° C. in order to solubilize completely the residual rifamycin S precipitate. 30 ml of 5% ascorbic acid solution in water was added thereto dropwisely while continuous stirring. The purpose color of rifamycin S was gradually changed to the deep red color of rifamycin SV. After adjusting the final pH to 4.0, the methanol was completely evaporated using suction evaporator at 40° C. Afte chilling the final solution at 4° C. for 2 days, the rifamycin SV crystals were recovered by filtration. 2.4 gr of deep yellowish rifamycin SV crystals were obtained after drying over sodium sulfate (yield=87%).

출처 및 근거

DOI10.6084/m9.figshare.5104873.v1
특허 번호US04431735
출처 데이터셋uspto-grants-1984_02
ORD IDord-835ab6c1bbac4370bf72cee22524c5c0
출처 메모uspto-grants-1984_02